Andagao, Cheryl V.

HRN: 06-28-78  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2023
CO-AMOXICLAV 625MG (TAB)
04/28/2023
05/05/2023
ORAL
625mg/tab
TID
UTI
Waiting Final Action 
05/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/01/2023
05/07/2023
IVTT
500 Mg
Q8
Infectious Diarrhea, T/c Amoebic Dysentery
Waiting Final Action 
05/03/2023
CO-AMOXICLAV 625MG (TAB)
05/03/2023
05/06/2023
PO
625mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: